A detailed history of Profund Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 39,754 shares of ARWR stock, worth $780,371. This represents 0.03% of its overall portfolio holdings.

Number of Shares
39,754
Previous 32,003 24.22%
Holding current value
$780,371
Previous $831,000 7.46%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.36 - $29.54 $150,059 - $228,964
7,751 Added 24.22%
39,754 $769,000
Q2 2024

Aug 13, 2024

SELL
$21.87 - $28.24 $370,849 - $478,865
-16,957 Reduced 34.63%
32,003 $831,000
Q1 2024

May 08, 2024

SELL
$27.21 - $39.48 $397,075 - $576,131
-14,593 Reduced 22.96%
48,960 $1.4 Million
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $204,283 - $299,005
9,636 Added 17.87%
63,553 $1.94 Million
Q3 2023

Nov 13, 2023

BUY
$26.2 - $36.08 $178,946 - $246,426
6,830 Added 14.51%
53,917 $1.45 Million
Q2 2023

Aug 10, 2023

SELL
$25.16 - $41.38 $143,789 - $236,486
-5,715 Reduced 10.82%
47,087 $1.68 Million
Q1 2023

May 11, 2023

BUY
$23.68 - $38.51 $824,135 - $1.34 Million
34,803 Added 193.36%
52,802 $1.34 Million
Q4 2022

Feb 02, 2023

BUY
$28.0 - $40.56 $14,644 - $21,212
523 Added 2.99%
17,999 $730,000
Q3 2022

Nov 04, 2022

SELL
$29.63 - $48.31 $9,363 - $15,265
-316 Reduced 1.78%
17,476 $578,000
Q2 2022

Aug 01, 2022

SELL
$27.79 - $50.61 $71,336 - $129,915
-2,567 Reduced 12.61%
17,792 $626,000
Q1 2022

May 10, 2022

SELL
$39.62 - $69.97 $81,339 - $143,648
-2,053 Reduced 9.16%
20,359 $936,000
Q4 2021

Feb 08, 2022

SELL
$58.09 - $82.51 $144,469 - $205,202
-2,487 Reduced 9.99%
22,412 $1.49 Million
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $958,599 - $1.4 Million
16,420 Added 193.65%
24,899 $1.55 Million
Q2 2021

Aug 12, 2021

SELL
$62.15 - $90.32 $14,978 - $21,767
-241 Reduced 2.76%
8,479 $702,000
Q1 2021

May 14, 2021

SELL
$61.35 - $90.47 $71,963 - $106,121
-1,173 Reduced 11.86%
8,720 $578,000
Q4 2020

Feb 09, 2021

BUY
$43.82 - $85.37 $27,475 - $53,526
627 Added 6.77%
9,893 $759,000
Q3 2020

Nov 13, 2020

BUY
$33.21 - $51.27 $111,485 - $172,113
3,357 Added 56.81%
9,266 $399,000
Q2 2020

Aug 03, 2020

BUY
$26.12 - $43.27 $154,343 - $255,682
5,909 New
5,909 $255,000
Q1 2020

May 15, 2020

SELL
$20.56 - $63.12 $195,607 - $600,523
-9,514 Closed
0 $0
Q4 2019

Feb 18, 2020

SELL
$28.14 - $73.01 $1,519 - $3,942
-54 Reduced 0.56%
9,514 $603,000
Q3 2019

Nov 12, 2019

BUY
$26.26 - $34.86 $7,300 - $9,691
278 Added 2.99%
9,568 $270,000
Q2 2019

Aug 13, 2019

BUY
$17.43 - $28.82 $161,924 - $267,737
9,290 New
9,290 $246,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.